Nexus Investment Management Ulc Pfizer Inc Transaction History

Nexus Investment Management Ulc

$1.02 Billion
Q3 2024

A detailed history of Nexus Investment Management Ulc transactions in Pfizer Inc stock. As of the latest transaction made, Nexus Investment Management Ulc holds 804,812 shares of PFE stock, worth $21.5 Million. This represents 2.29% of its overall portfolio holdings.

Number of Shares

804,812

Previous 800,257 0.57%

Holding current value

$21.5 Million

Previous $22.4 Million 4.02%

% of portfolio

2.29%

Previous 2.36%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$27.7 - $31.39 $126,173 - $142,981	4,555 Added 0.57%	804,812 $23.3 Million
Q2 2024 Jul 23, 2024	SELL	$25.26 - $29.6 $848,458 - $994,234	-33,589 Reduced 4.03%	800,257 $22.4 Million
Q1 2024 Apr 10, 2024	BUY	$25.89 - $29.73 $2.34 Million - $2.69 Million	90,470 Added 12.17%	833,846 $23.1 Million
Q4 2023 Jan 19, 2024	BUY	$26.13 - $33.94 $47,687 - $61,940	1,825 Added 0.25%	743,376 $21.4 Million
Q3 2023 Oct 11, 2023	BUY	$32.09 - $37.51 $186,763 - $218,308	5,820 Added 0.79%	741,551 $24.6 Million
Q2 2023 Jul 07, 2023	BUY	$36.12 - $41.79 $207,328 - $239,874	5,740 Added 0.79%	735,731 $27 Million
Q1 2023 Apr 04, 2023	BUY	$39.39 - $51.28 $718,867 - $935,860	18,250 Added 2.56%	729,991 $29.8 Million
Q4 2022 Jan 09, 2023	BUY	$41.75 - $54.5 $156,520 - $204,320	3,749 Added 0.53%	711,741 $36.5 Million
Q3 2022 Oct 07, 2022	BUY	$43.76 - $53.42 $259,278 - $316,513	5,925 Added 0.84%	707,992 $31 Million
Q2 2022 Jul 06, 2022	SELL	$46.53 - $55.17 $2.84 Million - $3.37 Million	-61,135 Reduced 8.01%	702,067 $36.8 Million
Q1 2022 Apr 08, 2022	SELL	$45.75 - $56.69 $474,427 - $587,875	-10,370 Reduced 1.34%	763,202 $39.5 Million
Q4 2021 Jan 13, 2022	BUY	$41.32 - $61.25 $59,914 - $88,812	1,450 Added 0.19%	773,572 $45.7 Million
Q3 2021 Oct 07, 2021	SELL	$39.25 - $50.42 $262,111 - $336,704	-6,678 Reduced 0.86%	772,122 $33.2 Million
Q2 2021 Jul 13, 2021	BUY	$35.91 - $40.68 $26,034 - $29,493	725 Added 0.09%	778,800 $30.5 Million
Q1 2021 Apr 09, 2021	BUY	$33.49 - $37.77 $1.21 Million - $1.37 Million	36,250 Added 4.89%	778,075 $28.2 Million
Q4 2020 Jan 11, 2021	BUY	$33.47 - $42.56 $577,357 - $734,160	17,250 Added 2.38%	741,825 $27.6 Million
Q3 2020 Oct 05, 2020	BUY	$31.75 - $37.25 $87,312 - $102,437	2,750 Added 0.38%	724,575 $26.6 Million
Q2 2020 Jul 08, 2020	BUY	$30.12 - $36.54 $237,948 - $288,666	7,900 Added 1.11%	721,825 $23.6 Million
Q1 2020 Apr 03, 2020	BUY	$27.03 - $38.62 $1 Million - $1.43 Million	37,130 Added 5.49%	713,925 $23.3 Million
Q4 2019 Jan 06, 2020	SELL	$32.92 - $37.36 $215,626 - $244,708	-6,550 Reduced 0.96%	676,795 $26.5 Million
Q3 2019 Oct 09, 2019	BUY	$32.49 - $42.13 $14,620 - $18,958	450 Added 0.07%	683,345 $24.6 Million
Q2 2019 Jul 12, 2019	BUY	$36.98 - $41.52 $516,610 - $580,034	13,970 Added 2.09%	682,895 $29.6 Million
Q1 2019 Apr 04, 2019	SELL	$37.5 - $41.2 $305,625 - $335,780	-8,150 Reduced 1.2%	668,925 $28.4 Million
Q4 2018 Jan 14, 2019	SELL	$38.47 - $43.86 $260,134 - $296,581	-6,762 Reduced 0.99%	677,075 $29.6 Million
Q3 2018 Oct 10, 2018	SELL	$34.47 - $41.81 $292,409 - $354,674	-8,483 Reduced 1.23%	683,837 $30.1 Million
Q2 2018 Jul 13, 2018	BUY	$32.98 - $35.16 $103,886 - $110,753	3,150 Added 0.46%	692,320 $25.1 Million
Q1 2018 Apr 05, 2018	BUY	$31.91 - $37.02 $1.3 Million - $1.5 Million	40,650 Added 6.27%	689,170 $24.5 Million
Q4 2017 Jan 11, 2018	SELL	$33.26 - $35.29 $131,377 - $139,395	-3,950 Reduced 0.61%	648,520 $23.5 Million
Q3 2017 Oct 12, 2017	BUY	$31.0 - $34.15 $20.2 Million - $22.3 Million	652,470	652,470 $23.3 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nexus Investment Management Ulc, based on Form 13F filings with the SEC.

News

Stay updated on Nexus Investment Management Ulc with notifications on news.

Account

Nexus Investment Management Ulc Pfizer Inc Transaction History